☆ 4.5 Article

Adverse reactions to the Bacillus Calmette-Guerin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial

VACCINE (2016)

期刊

VACCINE

卷 34, 期 22, 页码 2477-2482

出版社

ELSEVIER SCI LTD

DOI: 10.1016/j.vaccine.2016.03.100

关键词

BCG; Adverse reactions; Vaccines; Clinical trials; Non-specific effects; Children

类别

Immunology Medicine, Research & Experimental

资金

Danish National Research Foundation [DNRF108]

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

摘要

Objective: To evaluate adverse reactions of the Bacillus Calmette Guerin (BCG) Statens Serum Institut (SSI) (Danish strain 1331) used as intervention in a randomized clinical trial. Design: A randomized clinical multicenter trial, The Danish Calmette Study, randomizing newborns to BCG or no intervention. Follow-up until 13 months of age. Setting: Pediatric and maternity wards at three Danish university hospitals. Participants: All women planning to give birth at the three study sites (n = 16,521) during the recruitment period were invited to participate in the study. Four thousand one hundred and eighty four families consented to participate and 4262 children, gestational age 32 weeks and above, were randomized: 2129 to BCG vaccine and 2133 to no vaccine. None of the participants withdrew because of adverse reactions. Main outcome and measure: Trial-registered adverse reactions after BCG vaccination at birth. Follow-up at 3 and 13 months by telephone interviews and clinical examinations. Results: Among the 2118 BCG-vaccinated children we registered no cases of severe unexpected adverse reaction related to BCG vaccination and no cases of disseminated BCG disease. Two cases of regional lymphadenitis were hospitalized and thus classified as serious adverse reactions related to BCG. The most severe adverse reactions were 10 cases of suppurative lymphadenitis. This was nearly a fivefold increase compared to what was expected based on the summary of product characteristics of the vaccine. All cases were treated conservatively and recovered. Six of 10 (60%) families of children experiencing suppurative lymphadenitis compared to 117/2071 (6%) of those with no lymphadenitis indicated that the vaccine had more adverse effects than expected (p-value <0.001). Conclusions and relevance: BCG vaccination was associated with only mild morbidity and no mortality. A higher incidence of suppurative lymphadenitis than expected was observed. All children were treated conservatively without sequelae or complications. (C) 2016 The Authors. Published by Elsevier Ltd.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.5

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?

Christine S. Benn, Frederik Schaltz-Buchholzer, Sebastian Nielsen, Mihai G. Netea, Peter Aaby

Summary: We reviewed the randomized control trials of mRNA and adenovirus-vector COVID-19 vaccines to examine their possible non-specific effects. The mortality risk ratios (RRs) for mRNA COVID-19 vaccines vs. placebo recipients and adenovirus-vector COVID-19 vaccine recipients vs. controls were calculated. The overall mortality RR for mRNA vaccines vs. placebo was 1.03 (95% confidence interval [CI]: 0.63-1.71), while for adenovirus-vector vaccines, it was 0.37 (0.19-0.70). There was a significant difference between the two vaccine types in terms of overall mortality impact (p = 0.015). The unblinded and vaccinated control groups in the COVID-19 vaccine RCTs may not represent long-term effects. Randomized control trials comparing long-term effects on overall mortality between mRNA and adenovirus-vector vaccines are warranted.

ISCIENCE (2023)